Microfluidics, also referred to as lab-on-chip or micrototal analysis assisting in biological and chemical analysis, is a technology in the healthcare application that deals with the study of flow of liquids through microscopic channels. It is characterized by control and manipulation of fluids at sub-millimeter scale. Microfluidics involve design, manufacture and formulation of devices and processes dealing with extremely low volume of fluid and help in improved control of laboratory handling, analytical techniques and processing. Globally, advancements in proteomics and genomics field are expected to boost the growth of the microfluidics market during the period of study.
Geographically, North America dominated the microfluidics market driven by higher usage of advanced technological diagnostic materials in its best in class healthcare industry. North America was followed by Europe and Asia-Pacific as the second and third largest market for microfluidics market. Asia Pacific is projected to have the fastest growth, owing to rapidly developing healthcare infrastructure, increasing medical tourism and increasing spending by citizens for healthcare in developing nations such as China and India in this region.
- Thermo Fisher Scientific, Inc.
- Becton, Dickinson and Company
- Bio-Rad Laboratories, Inc.
- Perkinelmer, Inc
- Agilent Technologies, Inc
- Danaher Corporation
- Cepheid Inc.
- Fluidigm Corporation
- Biofluidix GmbH
- Bartels Mikrotechnik GmbH
Key Topics Covered:
1. Market Overview
2. Executive Summary
3. Market Landscape
4. Market Forces
5. Strategic Analysis
6. Microfluidics Market, By Material
7. Microfluidics Market, By Application
8. Microfluidics Market, By Geography
9. Microfluidics Market - Entropy
10. Company Profiles
For more information about this report visit http://www.researchandmarkets.com/research/gq5hnq/microfluidics